Distinguishing between endocrine disruption and non-specific effects on endocrine systems

Area of Science:

• Toxicology
• Endocrinology
• Pharmacology

Background:

• The endocrine system regulates growth, development, homeostasis, and physiological processes.
• Differentiating endocrine-mediated adverse effects from other responses is complex, particularly in toxicology studies using maximum tolerated doses.
• Systemic toxicity can impact endocrine signaling through non-endocrine mechanisms, necessitating careful distinction.

Purpose of the Study:

• To examine in vitro and in vivo endocrine endpoints that can be affected by non-endocrine processes.
• To recommend methods for evaluating these effects in chemical safety assessments.
• To highlight the importance of a weight of evidence (WoE) approach for determining endocrine-disrupting properties.

Main Methods:

• Review of in vitro and in vivo studies examining endocrine endpoints.
• Analysis of mechanisms by which non-endocrine processes can alter endocrine function.
• Evaluation of existing methodologies for assessing chemical effects on the endocrine system.

Main Results:

• Non-endocrine processes, such as systemic toxicity, can significantly alter endocrine endpoints.
• It is crucial to distinguish between direct endocrine-mediated effects and those caused by other toxicological mechanisms.
• Existing toxicological study designs may not adequately differentiate these effects.

Conclusions:

• A formal weight of evidence (WoE) approach is essential for accurately assessing the endocrine-disrupting potential of chemicals.
• Further refinement of methodologies is needed to distinguish endocrine-mediated from non-endocrine-mediated effects on the endocrine system.
• Understanding these distinctions is critical for robust chemical risk assessment and regulatory decision-making.